Information  X 
Enter a valid email address

PRS Finance PLC (55AN)

  Print      Mail a friend

Friday 08 February, 2019

PRS Finance PLC

Sale of Retained Bonds

RNS Number : 5302P
PRS Finance PLC
08 February 2019
 

Issuer: PRS Finance plc

Date: 8 February 2019

 

 

PRS FINANCE PLC

(the "Issuer")

(incorporated with limited liability in England and Wales

with registration number 09331085)

 

 

This announcement is released by PRS Finance plc and contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 (MAR). For the purposes of MAR and Article 2 of the Commission Implementing Regulation (EU) 2016/1055, this announcement is made by Susan Abrahams on behalf of Intertrust Directors 1 Limited as Director of PRS Finance plc.

Sale of Retained Bonds

 

PRS Finance Plc 2.00% Guaranteed Secured Bonds due 2029

 

(ISIN: XS1916263897, Common Code: 191626389)

 

(the "Bonds")

 

The Issuer is pleased to announce today that it has sold £38,000,000 in principal amount of its Bonds under the guaranteed secured bond programme established by the Issuer for the issue of bonds unconditionally and irrevocably guaranteed by the Secretary of State for Housing, Communities and Local Government (formerly being the Secretary of State for Communities and Local Government) (the "Programme").

 

In accordance with the terms and conditions of the Bonds, the Bonds that have been sold were Retained Bonds, as detailed in the Programme Memorandum dated 23 July 2018 (as supplemented by the Pricing Supplement dated 22 January 2019 in respect of the Bonds) (the "Programme Memorandum").

 

Following the sale, the aggregate outstanding principal amount of Bonds in issue will be £250,000,000 under the Programme, of which £87,000,000 are Retained Bonds held by or on behalf of the Issuer.

 

 

For further information please contact Venn Partners.

Email: [email protected]  

Tel: +44 (0)20 7073 9350

 

DISCLAIMER - INTENDED ADDRESSEES 

Please note that the information contained in the Programme Memorandum may be addressed to and/or targeted at persons who are residents of particular countries (specified therein) only and are not intended for use and should not be relied upon by any person outside these countries and/or to whom any offer of bonds under the Programme is not addressed. Prior to relying on the information contained in the Programme Memorandum, you must ascertain whether or not you are part of the intended addressees of the information contained therein. 

This announcement does not constitute an offering of securities and is not for distribution in the United States. The securities described in the Programme Memorandum (the "Securities") have not been, and will not be, registered under the U.S. Securities Act of 1933, as amended (the "Securities Act"), or under any relevant securities laws of any state of the United States of America and are subject to U.S. tax law requirements. Subject to certain exceptions, the Securities may not be offered or sold directly or indirectly within the United States or to, or for the account or benefit of, U.S. persons or to persons within the United States of America, as such terms are defined in Regulation S under the Securities Act.  Any forwarding, distribution or reproduction of the Programme Memorandum in whole or in part is prohibited. Failure to comply with this notice may result in a violation of the Securities Act or the applicable laws of other jurisdictions. There will be no public offering of the Securities in the United States.

Your right to access this service is conditional upon complying with the above requirements. In particular, your accessing this service will constitute your representation that you are not in the United States and you are not a U.S. person within the meaning of Regulation S under the Securities Act and the U.S. Internal Revenue Code and regulations thereunder.

END


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
DISUGUPPPUPBGPR

a d v e r t i s e m e n t